MicroRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  An, Liwen ^a   Liu, Yongjun ^a   Wu, Anhua ^a   Guan, Yifu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; MICRORNA 124; PROTEIN KINASE; PROTEIN ROCK1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACTIN FILAMENT; ARTICLE; CANCER GRADING; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; PROTEIN EXPRESSION; ROCK1 GENE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; ACTIN CYTOSKELETON; BASE SEQUENCE; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURFACE EXTENSIONS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HEK293 CELLS; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES;

EID: 84880737108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069478     Document Type: Article

References (69)

1. American Cancer Society.: Cancer Facts and Figures (2012). Atlanta GACS, 2012. Available: http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012. Accessed July 31, 2012.
2. Louis DN et al. (2007) WHO classification of tumours of the central nervous system. Lyon: World Health Organization Press. 312 p.
3. CBTRUS (2012). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008 (March 23, 2012 Revision).
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
5. Eulalio A, Huntzinger E, Izaurralde E, (2008) Getting to the Root of miRNA-Mediated Gene Silencing. Cell 132: 9-14.
6. Li Q, Bian S, Hong J, Kawase Koga Y, Zhu E, et al. (2011) Timing specific requirement of microRNA function is essential for embryonic and postnatal hippocampal development. PLoS One 6: e26000.
7. Chen CZ, Li L, Lodish HF, Bartel DP, (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
8. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM, (2003) bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36.
9. Chen CH, Guo M, Hay BA, (2006) Identifying microRNA regulators of cell death in Drosophila. Methods Mol Biol 342: 229-240.
10. Fu LL, Wen X, Bao JK, Liu B, (2012) MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 44: 733-736.
11. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999-3004.
12. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, et al. (2006) The colorectal microRNAome. Proc Natl Acad Sci U S A 103: 3687-3692.
13. Hwang HW, Mendell JT, (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94: 776-780.
14. Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, et al. (2012) microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27: 1019-1026.
15. Manikandan J, Aarthi JJ, Kumar SD, Pushparaj PN, (2008) Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2: 330-334.
16. Kong YW, Ferland McCollough D, Jackson TJ, Bushell M, (2012) microRNAs in cancer management. Lancet Oncol 13: e249-258.
17. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358.
18. Godlewski J, Newton HB, Chiocca EA, Lawler SE, (2010) MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ 17: 221-228.
19. Wurdinger T, Tannous BA, (2009) Glioma angiogenesis: Towards novel RNA therapeutics. Cell Adh Migr 3: 230-235.
20. Turner JD, Williamson R, Almefty KK, Nakaji P, Porter R, et al. (2010) The many roles of microRNAs in brain tumor biology. Neurosurg Focus 28: E3.
21. Pang JC, Kwok WK, Chen Z, Ng HK, (2009) Oncogenic role of microRNAs in brain tumors. Acta Neuropathol 117: 599-611.
22. Silber J, James CD, Hodgson JG, (2009) microRNAs in gliomas: small regulators of a big problem. Neuromolecular Med 11: 208-222.
23. Novakova J, Slaby O, Vyzula R, Michalek J, (2009) MicroRNA involvement in glioblastoma pathogenesis. Biochem Biophys Res Commun 386: 1-5.
24. Wong JW, (2010) MicroRNA-induced silencing of glioma progression. J Neurosci 30: 3868-3869.
25. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, et al. (2002) Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739.
26. Cao X, Pfaff SL, Gage FH, (2007) A functional study of miR-124 in the developing neural tube. Genes Dev 21: 531-536.
27. Pierson J, Hostager B, Fan R, Vibhakar R, (2008) Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 90: 1-7.
28. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14. Available: http://www.biomedcentral.com/1741-7015/6/14. Accessed 24 Jun 2008.
29. Huang TC, Chang HY, Chen CY, Wu PY, Lee H, et al. (2011) Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR. FEBS Letters 585: 3582-3586.
30. Xia J, Wu Z, Yu C, He W, Zheng H, et al. (2012) MiR-124 Inhibits Cell Proliferation in Gastric Cancer through Downregulation of SPHK1. The Journal of Pathology 227: 470-478.
31. Shi XB, Xue L, Ma AH, Tepper CG, Gandour Edwards R, et al. (2012) Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene. In press.
32. Li KK, Pang JC, Ching AK, Wong CK, Kong X, et al. (2009) miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40: 1234-1243.
33. Fowler A, Thomson D, Giles K, Maleki S, Mreich E, et al. (2011) miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer 47: 953-963.
34. Hunt S, Jones AV, Hinsley EE, Whawell SA, Lambert DW, (2011) MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Letters 585: 187-192.
35. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, et al. (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61: 278-289.
36. Barnholtz Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, et al. (2008) Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 108: 642-648.
37. Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, et al. (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120: 707-718.
38. Li D, Chen P, Li XY, Zhang LY, Xiong W, et al. (2011) Grade-Specific Expression Profiles of miRNAs/mRNAs and Docking Study in Human Grade I-III Astrocytomas. OMICS: A Journal of Integrative Biology 15: 673-682.
39. Xia H, Cheung WK, Ng SS, Jiang X, Jiang S, et al. (2012) Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. The Journal of biological chemistry 287: 9962-9971.
40. Katoh K, (2001) Stress fiber organization regulated by MLCK and Rho-kinase in cultured human fibroblasts. Am J Physiol Cell Physiol 280: C1669-C1679.
41. Shum MSY, Pasquier E, Pouha ST, ONeill GM, Chaponnier C, et al. (2011) γ-Actin regulates cell migration and modulates the ROCK signaling pathway. The FASEB Journal 25: 4423-4433.
42. Salhia B, Rutten F, Nakada M, Beaudry C, Berens M, et al. (2005) Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1. Cancer Res 65: 8792-8800.
43. Ishizaki T, Naito M, Fujisawa K, Maekawa M, Watanabe N, et al. (1997) p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Letters 404: 118-124.
44. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468.
45. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stuhler K, et al. (2010) Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 20: 539-550.
46. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70.
47. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
48. Alves CC, Carneiro F, Hoefler H, Becker KF, (2009) Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Frontiers in bioscience: a journal and virtual library 14: 3035-3050.
49. Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, et al. (2013) MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 34: 713-722.
50. Pellegrin S, Mellor H, (2007) Actin stress fibres. Journal of Cell Science 120: 3491-3499.
51. Lee SH, Dominguez R, (2010) Regulation of actin cytoskeleton dynamics in cells. Mol Cells 29: 311-325.
52. Tang AT, Campbell WB, Nithipatikom K, (2012) ROCK1 feedback regulation of the upstream small GTPase RhoA. Cellular Signalling 24: 1375-1380.
53. Riento K, Ridley AJ, (2003) Rocks: multifunctional kinases in cell behaviour. Nature Reviews Molecular Cell Biology 4: 446-456.
54. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, et al. (1996) ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392: 189-193.
55. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, et al. (2003) Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9: 2632-2641.
56. Kaneko K, Satoh K, Masamune A, Satoh A, Shimosegawa T, (2002) Expression of ROCK-1 in human pancreatic cancer: its down-regulation by morpholino oligo antisense can reduce the migration of pancreatic cancer cells in vitro. Pancreas 24: 251-257.
57. Spencer C, Montalvo J, McLaughlin SR, Bryan BA, (2011) Small molecule inhibition of cytoskeletal dynamics in melanoma tumors results in altered transcriptional expression patterns of key genes involved in tumor initiation and progression. Cancer Genomics Proteomics 8: 77-85.
58. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, et al. (2000) Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 269: 652-659.
59. Rattan R, Giri S, Singh AK, Singh I, (2006) Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res 83: 243-255.
60. Keller C, Kroening S, Zuehlke J, Kunath F, Krueger B, et al. (2012) Distinct mesenchymal alterations in N-cadherin and e-cadherin positive primary renal epithelial cells. PLoS One 7: e43584.
61. Deng L, Li G, Li R, Liu Q, He Q, et al. (2010) Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo. Cancer Biol Ther 9: 875-884.
62. Lin CC, Chen JT, Yang JS, Lu HF, Hsu SC, et al. (2009) Danthron inhibits the migration and invasion of human brain glioblastoma multiforme cells through the inhibition of mRNA expression of focal adhesion kinase, Rho kinases-1 and metalloproteinase-9. Oncol Rep 22: 1033-1037.
63. Shields MA, Krantz SB, Bentrem DJ, Dangi Garimella S, Munshi HG, (2012) Interplay between beta1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by snail and Slug proteins. The Journal of biological chemistry 287: 6218-6229.
64. Oellers P, Schroer U, Senner V, Paulus W, Thanos S, (2009) ROCKs are expressed in brain tumors and are required for glioma-cell migration on myelinated axons. Glia 57: 499-509.
65. Liao JK, Seto M, Noma K, (2007) Rho kinase (ROCK) inhibitors. Journal of cardiovascular pharmacology 50: 17-24.
66. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, et al. (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research 33: e179. Available: http://nar.oxfordjournals.org/content/33/20/e179.long. Accessed 7 Nov 2005.
67. Tang F, Hajkova P, Barton SC, Lao K, Surani MA. (2006) MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Research 34: e9. Available: http://nar.oxfordjournals.org/content/34/2/e9.long. Accessed 24 Jan 2006.
68. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
69. Machado CM, Schenka A, Vassallo J, Tamashiro WM, Goncalves EM, et al. (2005) Morphological characterization of a human glioma cell line. Cancer cell international 5: 13. Available: http://www.cancerci.com/content/5/1/13. Accessed 10 May 2005.